Advanced search
Publication Cover
Cancer Investigation Volume 19, 2001 - Issue 8
Submit an article Journal homepage
109
Views
35
CrossRef citations to date
0
Altmetric
Original

The Efficacy and Safety of Once-Daily Kytril® (Granisetron Hydrochloride) Tablets in the Prophylaxis of Nausea and Emesis Following Fractionated Upper Abdominal Radiotherapy

Rachelle Lanciano Delaware County Memorial Hospital, 501 N. Lansdowne Avenue, Drexel Hill, PA, 19026, U.S.A.; Department of Radiation Oncology, Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, U.S.A.
, M.D.,
David M. Sherman Department of Radiation Oncology, St. Joseph's Hospital, Milwaukee, Wisconsin, U.S.A.
, M.D.,
Jeffery Michalski Radiation Oncology Center, Washington University School of Medicine, St. Louis, Missouri, U.S.A.
, M.D., Ph.D.,
Alaknanda J. Preston SmithKline Beecham Pharmaceuticals, Clinical Research, Development and Medical Affairs, Collegeville, Pennsylvania, U.S.A.
, M.S.,
Karen Yocom SmithKline Beecham Pharmaceuticals, Clinical Research, Development and Medical Affairs, Collegeville, Pennsylvania, U.S.A.
, B.S.N. &
Carl Friedman SmithKline Beecham Pharmaceuticals, Clinical Research, Development and Medical Affairs, Collegeville, Pennsylvania, U.S.A.
, M.D.
Pages 763-772 | Published online: 30 Nov 2001

REFERENCES

  • Maisano R., Pergolizzi S., Settineri N. Escalating Dose of Oral Ondansetron in the Prevention of Radiation Induced Emesis. Anticancer Res. 1998; 18: 2011–2014
  • Roberts J. T., Priestman T. J. A Review of Ondansetron in the Management of Radiotherapy-Induced Emesis. Oncology 1993; 50: 173–179
  • Roila F., Ciccarese G., Palladina M., et al. Prevention of Radiotherapy-Induced Emesis. Tumori 1998; 84: 274–278
  • Scarantino C. W., Ornitz R. D., Hoffman L. G., et al. Radiation-Induced Emesis: Effects of Ondansetron. Semin. Oncol. 1992; 19: 38–43
  • Aapro M. Review of Experience with Ondansetron and Granisetron. Ann. Oncol. 1993; 4: S9–S14
  • Cunningham R. 5-HT3-Receptor Antagonists: A Review of Pharmacology and Clinical Efficacy. Oncol. Nurs. Forum 1997; 24: 33–40
  • Gunning S., Hagan R., Tyers B. Cisplatin Induces Biochemical and Histological Changes in the Small Intestine of the Ferret. Br. J. Pharm. 1987; 90: 135
  • Wickham R. Nausea and Vomiting. Cancer Symptom Management, S. Groenwald, M. H. Frogge, M. Goodman, C. H. Yarbro. Jones and Bartlett, Sudbury, MA 1996, Chapter 13
  • Andrews P., Hawthorn J., Sanger G. The Effect of Abdominal Visceral Nerve Lesions and a Novel 5HT-M Receptor Antagonist on Cytotoxic and Radiation Induced Emesis in the Ferret. J. Physiol. 1986; 382: 47
  • Hirabayashi N., Goto S., Morishima Y., et al. Efficacy of Granisetron, a 5HT3 Antagonist, in the Prevention of Nausea and Vomiting Induced by Conditioning for Hematopoietic Stem Cell Transplantation. Rinsho Ketsueki 1998; 39: 21–26, (abstract)
  • Logue J. P., Magee B., Hunter R. D., et al. The Antiemetic Effect of Granisetron in Lower Hemibody Radiotherapy. Clin. Oncol. 1991; 3: 247–249
  • Prentice H. G., Cunningham S., Gandhi L., et al. Granisetron in the Prevention of Irradiation-Induced Emesis. Bone Marrow Transplant. 1995; 15: 445–448
  • Kytril® (package insert). SmithKline Beecham Pharmaceuticals, Philadelphia, PA 1997
  • Krengli K., Lazzari R., Manara M. The Use of Granisetron Per Os in Radiotherapy-Induced Emesis. Minerva Med. 1996; 8: 605–608, (abstract)
  • Henriksson R., Lomberg H., Israelsson G., et al. The Effect of Ondansetron on Radiation-Induced Emesis and Diarrhoea. Acta Oncol. 1992; 31: 767–769
  • Priestman T. J., Roberts J. T., Lucraft H., et al. Results of a Randomized, Double-Blind Comparison Study of Ondansetron and Metoclopramide in the Prevention of Nausea and Vomiting Following High-Dose Upper Abdominal Irradiation. Clin. Oncol. 1990; 2: 71–75
  • Schwella N., Konig V., Schwerdtfeger R., et al. Ondansetron for Efficient Emesis Control During Total Body Irradiation. Bone Marrow Transplant. 1994; 13: 169–171
  • Spitzer T. R., Bryson J. C., Cirenza E., et al. Randomized Double-Blind, Placebo-Controlled Evaluation of Oral Ondansetron in the Prevention of Nausea and Vomiting Associated with Fractionated Total-Body Irradiation. J. Clin. Oncol. 1994; 12: 2432–2438
  • Priestman T. J., Roberts J. T., Upadhyaya B. K. A Prospective Randomized Double-Blind Trial Comparing Ondansetron Versus Prochlorperazine for the Prevention of Nausea and Vomiting in Patients Undergoing Fractioned Radiotherapy. Clin. Oncol. 1993; 5: 358–363

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.